The performance of diabetes risk prediction models in new populations: the role of ethnicity of the development cohort. Tanamas, Stephanie K.; Magliano, Dianna J.; Balkau, Beverley; Tuomilehto, Jaakko; Kowlessur, Sudhir; Söderberg, Stefan; Zimmet, Paul Z.; Shaw, Jonathan E.. Acta Diabetologica. 2015; 91-101: p.91-101. doi:10.1007/s00592-014-0607-xArticle
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G.. J Neurooncol. 2015; 307-14: p.307-14. doi:10.1007/s11060-015-1802-5 10.1007/s11060-015-1802-5. Epub 2015 May 15.Article
Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling. Gross, Priscilla; Massy, Ziad A.; Henaut, Lucie; Boudot, Cédric; Cagnard, Joanna; March, Cécilia; Kamel, Saïd; Drüeke, Tilman B.; Six, Isabelle. Journal of Cellular Physiology. 2015; 2927-2935: p.2927-2935. doi:10.1002/jcp.25018Article
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models. Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.. Value Health. 2015; A704: p.A704. doi:10.1016/j.jval.2015.09.2639 10.1016/j.jval.2015.09.2639. Epub 2015 Oct 20.Article
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Favennec, Marie; Hennart, Benjamin; Caiazzo, Robert; Leloire, Audrey; Yengo, Loïc; Verbanck, Marie; Arredouani, Abdelilah; Marre, Michel; Pigeyre, Marie; Bessede, Alban; Guillemin, Gilles J.; Chinetti, Giulia; Staels, Bart; Pattou, François; Balkau, Beverley; Allorge, Delphine; Froguel, Philippe; Poulain-Godefroy, Odile. Obesity (Silver Spring, Md.). 2015; : . doi:10.1002/oby.21199Article
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.. Ann. Oncol.. 2015; 2505-6: p.2505-6Article
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Kernéis, Solen; Valade, Sandrine; Geri, Guillaume; Compain, Fabrice; Lavollay, Marie; Rostane, Hidayeth; Carbonnelle, Etienne; Mainardi, Jean-Luc. Infectious Diseases (London, England). 2015; 47: p.789-795. doi:10.3109/23744235.2015.1062133Article
Dose finding with longitudinal data: simpler models, richer outcomes. Paoletti, X.; Doussau, A.; Ezzalfani, M.; Rizzo, E.; Thiebaut, R.. Stat Med. 2015; 2983-98: p.2983-98. doi:10.1002/sim.6552 10.1002/sim.6552. Epub 2015 Jun 24.Article
Why do liver transplant patients so often become obese? The addiction transfer hypothesis. Brunault, P.; Salame, E.; Jaafari, N.; Courtois, R.; Reveillere, C.; Silvain, C.; Benyamina, A.; Blecha, L.; Belin, D.; Ballon, N.. Med hypotheses. 2015; 68-75: p.68-75. doi:10.1016/j.mehy.2015.03.026Article
Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes). Farsalinos, K. E.; Le Houezec, J.. Risk Manag Healthc Policy. 2015; 157-67: p.157-67Article
Oncostat
Épidémiologie clinique